We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

LabMedica

Download Mobile App
Recent News Expo Clinical Chem. Molecular Diagnostics Hematology Immunology Microbiology Pathology Technology Industry Focus

New Technique Reduces Loss of MicroRNAs from Biological Specimens

By LabMedica International staff writers
Posted on 16 Feb 2009
A recent publication described the development of a technique for preventing microRNAs, small regulatory RNAs with many biological functions and disease associations, from leaking from biological specimens during fixation.

Usually biological specimens such as tissues or cells are treated with a cross linking agent such as formaldehyde to fix molecules in place. The agent locks the specimen's macromolecules into a type of minute scaffolding, but as explained by first author Dr. John Pena, assistant professor of molecular biology at the Rockefeller University (New York, NY, USA), "Because microRNAs are so small, they come out of the tissue. They just fall through the scaffold."

Dr. Pena and his colleagues reported in the January 11, 2009, online edition of the journal Nature Methods that the loss of microRNAs from formaldehyde-fixed tissues could be prevented by subsequent fixation with 1-ethyl-3-(3-dimethylaminopropyl) carbodiimide (EDC). This treatment irreversibly immobilized the microRNA at its 5' phosphate end.

They tested this method on more than 130 microRNAs in an assortment of tissues including heart, liver, muscle, and brain. Results showed that retention of microRNAs by tissues treated with formaldehyde and EDC was consistently greater than in tissues treated with formaldehyde alone.

"If microRNAs are going to be used as a diagnostic tool, we need a reliable way to measure them in normal and disease tissue, regardless of where or to what degree they are expressed," said Dr. Pena. "So that is what we did: We went back and examined and questioned every single step of this protocol to see where we could optimize it. In order to move forward, we had to go to the basics."

Related Links:
Rockefeller University



Platinum Member
Automated Coagulation Analyzer
Hemolumi H6
Gold Member
Neonatal Heel Incision Device
Tenderfoot
Automatic CLIA Analyzer
Shine i6000
New
Microbiology Laboratory Automation Solution
BD Kiestra™ ReadA+BarcodA

Latest BioResearch News

Circulating Tumor DNA Helps Identify Targets for Personalized Immunotherapy
16 Feb 2009  |   BioResearch

Researchers Classify 108 Lysosomal Disorders in Updated Diagnostic Framework
16 Feb 2009  |   BioResearch

New Autoantibody Target Identified in Neuromyelitis Optica Spectrum Disorder
16 Feb 2009  |   BioResearch